請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/37261
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 王兆麟(Jaw-Lin Wang) | |
dc.contributor.author | Jong-Kai Hsiao | en |
dc.contributor.author | 蕭仲凱 | zh_TW |
dc.date.accessioned | 2021-06-13T15:22:46Z | - |
dc.date.available | 2011-07-24 | |
dc.date.copyright | 2008-07-24 | |
dc.date.issued | 2008 | |
dc.date.submitted | 2008-07-21 | |
dc.identifier.citation | 1. Brownell GL, Budinger TF, Lauterbur PC, McGeer PL. Positron Tomography and Nuclear Magnetic Resonance Imaging. Science 1982;215(4533):619-626.
2. Haase A, Frahm J, Hanicke W, Matthaei D. 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 1985;30(4):341-344. 3. Lauterbur PC. Progress in n.m.r. zeugmatography imaging. Philos Trans R Soc Lond B Biol Sci 1980;289(1037):483-487. 4. Weinmann HJ, Brasch RC, Press WR, Wesbey GE. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR Am J Roentgenol 1984;142(3):619-624. 5. Bluemke DA, Sahani D, Amendola M, Balzer T, Breuer J, Brown JJ, Casalino DD, Davis PL, Francis IR, Krinsky G, Lee FT, Jr., Lu D, Paulson EK, Schwartz LH, Siegelman ES, for the G. Efficacy and Safety of MR Imaging with Liver-specific Contrast Agent: U.S. Multicenter Phase III Study. Radiology 2005;237(1):89-98. 6. Idee JM, Port M, Medina C, Lancelot E, Fayoux E, Ballet S, Corot C. Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: A critical review. Toxicology 2008;248(2-3):77-88. 7. Caccetta T, Chan JJ. Nephrogenic systemic fibrosis associated with liver transplantation, renal failure and gadolinium. Australas J Dermatol 2008;49(1):48-51. 8. Kurtkoti J, Snow T, Hiremagalur B. Gadolinium and nephrogenic systemic fibrosis: association or causation. Nephrology (Carlton) 2008;13(3):235-241. 9. Tsai CP, Hung Y, Chou YH, Huang DM, Hsiao JK, Chang C, Chen YC, Mou CY. High-contrast paramagnetic fluorescent mesoporous silica nanorods as a multifunctional cell-imaging probe. Small 2008;4(2):186-191. 10. Anderson SA, Lee KK, Frank JA. Gadolinium-fullerenol as a paramagnetic contrast agent for cellular imaging. Invest Radiol 2006;41(3):332-338. 11. Mulder WJ, Strijkers GJ, Briley-Saboe KC, Frias JC, Aguinaldo JG, Vucic E, Amirbekian V, Tang C, Chin PT, Nicolay K, Fayad ZA. Molecular imaging of macrophages in atherosclerotic plaques using bimodal PEG-micelles. Magn Reson Med 2007;58(6):1164-1170. 12. Bremer C, Allkemper T, Baermig J, Reimer P. RES-specific imaging of the liver and spleen with iron oxide particles designed for blood pool MR-angiography. J Magn Reson Imaging 1999;10(3):461-467. 13. Sun R, Dittrich J, Le-Huu M, Mueller MM, Bedke J, Kartenbeck J, Lehmann WD, Krueger R, Bock M, Huss R, Seliger C, Grone HJ, Misselwitz B, Semmler W, Kiessling F. Physical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells: a comparison. Invest Radiol 2005;40(8):504-513. 14. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol 1989;152(1):167-173. 15. Hsiao JK, Chu HH, Wang YH, Lai CW, Chou PT, Hsieh ST, Wang JL, Liu HM. Macrophage physiological function after superparamagnetic iron oxide labeling. NMR Biomed 2008. 16. Kircher MF, Allport JR, Graves EE, Love V, Josephson L, Lichtman AH, Weissleder R. In Vivo High Resolution Three-Dimensional Imaging of Antigen-Specific Cytotoxic T-Lymphocyte Trafficking to Tumors Cancer Res 2003;63(20):6838-6846. 17. Zhao M, Beauregard DA, Loizou L, Davletov B, Brindle KM. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat Med 2001;7(11):1241-1244. 18. Remsen LG, McCormick CI, Roman-Goldstein S, Nilaver G, Weissleder R, Bogdanov A, Hellstrom I, Kroll RA, Neuwelt EA. MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis. AJNR Am J Neuroradiol 1996;17(3):411-418. 19. Anderson SA, Rader RK, Westlin WF, Null C, Jackson D, Lanza GM, Wickline SA, Kotyk JJ. Magnetic resonance contrast enhancement of neovasculature with alpha(v)beta(3)-targeted nanoparticles. Magn Reson Med 2000;44(3):433-439. 20. Lai CW, Wang YH, Lai CH, Yang MJ, Chen CY, Chou PT, Chan CS, Chi Y, Chen YC, Hsiao JK. Iridium-complex-functionalized Fe3O4/SiO2 core/shell nanoparticles: a facile three-in-one system in magnetic resonance imaging, luminescence imaging, and photodynamic therapy. Small 2008;4(2):218-224. 21. Ittrich H, Lange C, Dahnke H, Zander AR, Adam G, Nolte-Ernsting C. Labeling of Mesenchymal Stem Cells with Different Superparamagnetic Particles of Iron Oxide and Detectability with MRI at 3T. Rofo 2005(08):1151-1163. 22. Lutz AM, Weishaupt D, Persohn E, Goepfert K, Froehlich J, Sasse B, Gottschalk J, Marincek B, Kaim AH. Imaging of Macrophages in Soft-Tissue Infection in Rats: Relationship between Ultrasmall Superparamagnetic Iron Oxide Dose and MR Signal Characteristics. Radiology 2005;234(3):765-775. 23. Hsiao JK, Tai MF, Chu HH, Chen ST, Li H, Lai DM, Hsieh ST, Wang JL, Liu HM. Magnetic nanoparticle labeling of mesenchymal stem cells without transfection agent: cellular behavior and capability of detection with clinical 1.5 T magnetic resonance at the single cell level. Magn Reson Med 2007;58(4):717-724. 24. Lu CW, Hung Y, Hsiao JK, Yao M, Chung TH, Lin YS, Wu SH, Hsu SC, Liu HM, Mou CY, Yang CS, Huang DM, Chen YC. Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling. Nano Lett 2007;7(1):149-154. 25. Liu HM, Wu SH, Lu CW, Yao M, Hsiao JK, Hung Y, Lin YS, Mou CY, Yang CS, Huang DM, Chen YC. Mesoporous silica nanoparticles improve magnetic labeling efficiency in human stem cells. Small 2008;4(5):619-626. 26. Weissleder R, Mahmood U. Molecular Imaging. Radiology 2001;219(2):316-333. 27. Weissleder R. Molecular imaging: exploring the next frontier. Radiology 1999;212(3):609-614. 28. Weissleder R, Pittet MJ. Imaging in the era of molecular oncology. Nature 2008;452(7187):580-589. 29. Shah K, Weissleder R. Molecular optical imaging: applications leading to the development of present day therapeutics. NeuroRx 2005;2(2):215-225. 30. Tung CH, Mahmood U, Bredow S, Weissleder R. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res 2000;60(17):4953-4958. 31. Hsiao J-K, Law B, Weissleder R, Tung C-H. In-vivo imaging of tumor associated urokinase-type plasminogen activator activity. Journal of Biomedical Optics 2006;11(3):034013-034015. 32. Bremer C, Ntziachristos V, Weissleder R. Optical-based molecular imaging: contrast agents and potential medical applications. Eur Radiol 2003;13(2):231-243. 33. Weissleder R, Imhof H. [Molecular imaging--a new emphasis in radiology]. Radiologe 2007;47(1):6-7. 34. Mahmood U, Weissleder R. Some tools for molecular imaging. Acad Radiol 2002;9(6):629-631. 35. Nahrendorf M, Sosnovik DE, Weissleder R. MR-optical imaging of cardiovascular molecular targets. Basic Res Cardiol 2008;103(2):87-94. 36. Kamaly N, Kalber T, Ahmad A, Oliver MH, So PW, Herlihy AH, Bell JD, Jorgensen MR, Miller AD. Bimodal paramagnetic and fluorescent liposomes for cellular and tumor magnetic resonance imaging. Bioconjug Chem 2008;19(1):118-129. 37. Hoehn M, Himmelreich U, Kruttwig K, Wiedermann D. Molecular and cellular MR imaging: potentials and challenges for neurological applications. J Magn Reson Imaging 2008;27(5):941-954. 38. Reimer P, Balzer T. Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol 2003;13(6):1266-1276. 39. Catherine CB, Adam SGC. Functionalisation of magnetic nanoparticles for applications in biomedicine. J Phys D: Appl Phys 2003;36(13):R198. 40. Nel A, Xia T, Madler L, Li N. Toxic Potential of Materials at the Nanolevel. Science 2006;311(5761):622-627. 41. Arbab AS, Yocum GT, Rad AM, Khakoo AY, Fellowes V, Read EJ, Frank JA. Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed 2005;18(8):553-559. 42. Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, Khakoo AY, Read EJ, Frank JA. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 2004;104(4):1217-1223. 43. Pawelczyk E, Arbab AS, Pandit S, Hu E, Frank JA. Expression of transferrin receptor and ferritin following ferumoxides-protamine sulfate labeling of cells: implications for cellular magnetic resonance imaging. NMR Biomed 2006;19(5):581-592. 44. Cai W, Shin DW, Chen K, Gheysens O, Cao Q, Wang SX, Gambhir SS, Chen X. Peptide-Labeled Near-Infrared Quantum Dots for Imaging Tumor Vasculature in Living Subjects. Nano Lett 2006;6(4):669-676. 45. Moghimi SM, Hunter AC, Murray JC. Nanomedicine: current status and future prospects. FASEB J 2005;19(3):311-330. 46. Muller J, Huaux F, Moreau N, Misson P, Heilier JF, Delos M, Arras M, Fonseca A, Nagy JB, Lison D. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol Appl Pharmacol 2005;207(3):221-231. 47. Pestka S, Langer JA, Zoon KC, Samuel CE. Interferons and their actions. Annu Rev Biochem 1987;56:727-777. 48. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288(5789):373-376. 49. Bosca L, Zeini M, Traves PG, Hortelano S. Nitric oxide and cell viability in inflammatory cells: a role for NO in macrophage function and fate. Toxicology 2005;208(2):249-258. 50. Nathan C, Shiloh MU. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. PNAS 2000;97(16):8841-8848. 51. Metz S, Bonaterra G, Rudelius M, Settles M, Rummeny EJ, Daldrup-Link HE. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur Radiol 2004;14(10):1851-1858. 52. Oude Engberink RD, van der Pol SMA, Dopp EA, de Vries HE, Blezer ELA. Comparison of SPIO and USPIO for in Vitro Labeling of Human Monocytes: MR Detection and Cell Function. Radiology 2007;243(2):467-474. 53. Raynal I, Prigent P, Peyramaure S, Najid A, Rebuzzi C, Corot C. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol 2004;39(1):56-63. 54. Daldrup-Link HE, Rudelius M, Oostendorp RAJ, Settles M, Piontek G, Metz S, Rosenbrock H, Keller U, Heinzmann U, Rummeny EJ, Schlegel J, Link TM. Targeting of Hematopoietic Progenitor Cells with MR Contrast Agents. Radiology 2003;228(3):760-767. 55. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65(1-2):55-63. 56. Kotani N, Hashimoto H, Sessler DI, Kikuchi A, Suzuki A, Takahashi S, Muraoka M, Matsuki A. Intraoperative modulation of alveolar macrophage function during isoflurane and propofol anesthesia. Anesthesiology 1998;89(5):1125-1132. 57. Chen JJW, Lin YC, Yao PL, Yuan A, Chen HY, Shun CT, Tsai MF, Chen CH, Yang PC. Tumor-Associated Macrophages: The Double-Edged Sword in Cancer Progression. J Clin Oncol 2005;23(5):953-964. 58. Chang Y, Chen TL, Sheu JR, Chen RM. Suppressive effects of ketamine on macrophage functions. Toxicol Appl Pharmacol 2005;204(1):27-35. 59. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982;126(1):131-138. 60. Chnari E, Nikitczuk JS, Uhrich KE, Moghe PV. Nanoscale anionic macromolecules can inhibit cellular uptake of differentially oxidized LDL. Biomacromolecules 2006;7(2):597-603. 61. Kagan VE, Tyurina YY, Tyurin VA, Konduru NV, Potapovich AI, Osipov AN, Kisin ER, Schwegler-Berry D, Mercer R, Castranova V, Shvedova AA. Direct and indirect effects of single walled carbon nanotubes on RAW 264.7 macrophages: Role of iron. Toxicol Lett 2006;165(1):88-100. 62. Stout RD, Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 2004;76(3):509-513. 63. Tracey KJ, Wei H, Manogue KR, Fong Y, Hesse DG, Nguyen HT, Kuo GC, Beutler B, Cotran RS, Cerami A, Lowry SF. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med 1988;167(3):1211-1227. 64. Beutler B, Cerami A. Cachectin (tumor necrosis factor): a macrophage hormone governing cellular metabolism and inflammatory response. Endocr Rev 1988;9(1):57-66. 65. Arbab AS, Wilson LB, Ashari P, Jordan EK, Lewis BK, Frank JA. A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging. NMR Biomed 2005;18(6):383-389. 66. Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 2004;17(7):484-499. 67. Kraitchman DL, Heldman AW, Atalar E, Amado LC, Martin BJ, Pittenger MF, Hare JM, Bulte JWM. In Vivo Magnetic Resonance Imaging of Mesenchymal Stem Cells in Myocardial Infarction. Circulation 2003;107(18):2290-2293. 68. Magnitsky S, Watson DJ, Walton RM, Pickup S, Bulte JWM, Wolfe JH, Poptani H. In vivo and ex vivo MRI detection of localized and disseminated neural stem cell grafts in the mouse brain. Neuroimage 2005;26(3):744-754. 69. Hauger O, Frost EE, van Heeswijk R, Deminiere C, Xue R, Delmas Y, Combe C, Moonen CTW, Grenier N, Bulte JWM. MR Evaluation of the Glomerular Homing of Magnetically Labeled Mesenchymal Stem Cells in a Rat Model of Nephropathy. Radiology 2006;238(1):200-210. 70. Berkova Z, Jirak D, Zacharovova K, Kriz J, Lodererova A, Girman P, Koblas T, Dovolilova E, Vancova M, Hajek M, Saudek F. Labeling of pancreatic islets with iron oxide nanoparticles for in vivo detection with magnetic resonance. Transplantation 2008;85(1):155-159. 71. Arbab AS, Frenkel V, Pandit SD, Anderson SA, Yocum GT, Bur M, Khuu HM, Read EJ, Frank JA. Magnetic Resonance Imaging and Confocal Microscopy Studies of Magnetically Labeled Endothelial Progenitor Cells Trafficking to Sites of Tumor Angiogenesis. Stem Cells 2006;24(3):671-678. 72. Matuszewski L, Persigehl T, Wall A, Schwindt W, Tombach B, Fobker M, Poremba C, Ebert W, Heindel W, Bremer C. Cell Tagging with Clinically Approved Iron Oxides: Feasibility and Effect of Lipofection, Particle Size, and Surface Coating on Labeling Efficiency. Radiology 2005;235(1):155-161. 73. Shapiro EM, Skrtic S, Koretsky AP. Sizing it up: Cellular MRI using micron-sized iron oxide particles. Magn Reson Med 2005;53(2):329-338. 74. Shapiro EM, Sharer K, Skrtic S, Koretsky AP. In vivo detection of single cells by MRI. Magn Reson Med 2006;55(2):242-249. 75. Dodd SJ, Williams M, Suhan JP, Williams DS, Koretsky AP, Ho C. Detection of Single Mammalian Cells by High-Resolution Magnetic Resonance Imaging. Biophys J 1999;76(1):103-109. 76. Heyn C, Bowen CV, Rutt BK, Foster PJ. Detection threshold of single SPIO-labeled cells with FIESTA. Magn Reson Med 2005;53(2):312-320. 77. Foster-Gareau P, Heyn C, Alejski A, Rutt BK. Imaging single mammalian cells with a 1.5 T clinical MRI scanner. Magn Reson Med 2003;49(5):968-971. 78. Okamoto T, Aoyama T, Nakayama T, Nakamata T, Hosaka T, Nishijo K, Nakamura T, Kiyono T, Toguchida J. Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells. Biochem Biophys Res Commun 2002;295(2):354-361. 79. Hsiao JK, Tai MF, Lee YC, Yang CY, Wang HY, Liu HM, Fang JS, Chen ST. Labelling of cultured macrophages with novel magnetic nanoparticles. J Magn Magn Mater 2006;304(1):e4-e6. 80. Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Macho A, Haeffner A, Hirsch F, Geuskens M, Kroemer G. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med 1996;184(3):1155-1160. 81. McBeath R, Pirone DM, Nelson CM, Bhadriraju K, Chen CS. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Developmental cell 2004;6(4):483-495. 82. Muller K, Skepper JN, Tang TY, Graves MJ, Patterson AJ, Corot C, Lancelot E, Thompson PW, Brown AP, Gillard JH. Atorvastatin and uptake of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) in human monocyte-macrophages: implications for magnetic resonance imaging. Biomaterials 2008;29(17):2656-2662. 83. Rice HE, Hsu EW, Sheng H, Evenson DA, Freemerman AJ, Safford KM, Provenzale JM, Warner DS, Johnson GA. Superparamagnetic iron oxide labeling and transplantation of adipose-derived stem cells in middle cerebral artery occlusion-injured mice. AJR Am J Roentgenol 2007;188(4):1101-1108. 84. Walczak P, Kedziorek DA, Gilad AA, Lin S, Bulte JWM. Instant MR labeling of stem cells using magnetoelectroporation. Magn Reson Med 2005;54(4):769-774. 85. Zhang Z, Bos EJvd, Wielopolski PA, Jong-Popijus Md, Bernsen MR, Duncker DJ, Krestin GP. In vitro imaging of single living human umbilical vein endothelial cells with a clinical 3.0-T MRI scanner. MAGMA 2005;18(4):175-185. 86. Papucci L, Schiavone N, Witort E, Donnini M, Lapucci A, Tempestini A, Formigli L, Zecchi-Orlandini S, Orlandini G, Carella G, Brancato R, Capaccioli S. Coenzyme Q10 Prevents Apoptosis by Inhibiting Mitochondrial Depolarization Independently of Its Free Radical Scavenging Property. J Biol Chem 2003;278(30):28220-28228. 87. Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharmacol 2005;202(2):199-211. 88. Zhang Z, van den Bos EJ, Wielopolski PA, de Jong-Popijus M, Duncker DJ, Krestin GP. High-resolution magnetic resonance imaging of iron-labeled myoblasts using a standard 1.5-T clinical scanner. MAGMA 2004;17(3 - 6):201-209. 89. Nahrendorf M, Jaffer FA, Kelly KA, Sosnovik DE, Aikawa E, Libby P, Weissleder R. Noninvasive Vascular Cell Adhesion Molecule-1 Imaging Identifies Inflammatory Activation of Cells in Atherosclerosis. Circulation 2006;114(14):1504-1511. 90. Wu YL, Ye Q, Foley LM, Hitchens TK, Sato K, Williams JB, Ho C. In situ labeling of immune cells with iron oxide particles: An approach to detect organ rejection by cellular MRI. PNAS 2006;103(6):1852-1857. 91. Kitchens WH, Chase CM, Uehara S, Cornell LD, Colvin RB, Russell PS, Madsen JC. Macrophage depletion suppresses cardiac allograft vasculopathy in mice. Am J Transplant 2007;7(12):2675-2682. 92. Takahashi M, Uematsu H, Hatabu H. MR imaging at high magnetic fields. Eur J Radiol 2003;46(1):45-52. 93. Coller SP, Paulnock DM. Signaling pathways initiated in macrophages after engagement of type A scavenger receptors. J Leukoc Biol 2001;70(1):142-148. 94. Terrovitis J, Stuber M, Youssef A, Preece S, Leppo M, Kizana E, Schar M, Gerstenblith G, Weiss RG, Marban E, Abraham MR. Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart. Circulation 2008;117(12):1555-1562. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/37261 | - |
dc.description.abstract | 氧化鐵奈米粒子是最近十幾年開發出來的磁振造影對比劑,具有超順磁以及奈米的物理特性,其化學組成為氧化鐵的核心加上外層包覆可分解的高分子用來增加水溶性以及懸浮性.在臨床的使用上可以用來標示肝臟內的網狀內皮細胞以及身體其他部位的巨噬細胞,作為肝臟腫瘤的偵測以及鑑別診斷的工具.由於氧化鐵奈米粒子是少數可以應用於臨床的奈米粒子,因此其生物特性特別令人感到好奇.因此我們對於氧化鐵奈米粒子與巨噬細胞的交互作用,細胞激素,吞噬能力等進行了一系列的分析以及探討.
當巨噬細胞將氧化鐵奈米粒子吞噬之後,我們在光學顯微鏡以及電子顯微鏡下發現,這些氧化鐵奈米粒子分布在細胞質的溶小體中,這個發現與其他研究的結果相符.同時巨噬細胞在吞噬大量的氧化鐵奈米粒子之後,其吞噬作用的能力有下降的情形產生,同時其分泌腫瘤壞死因子,一氧化氮的能力上升,這些現象代表了氧化鐵奈米粒子會影響到巨噬細胞的生理功能,我們並且發現了這些生理功能的變化,都是在巨噬細胞培養在濃度為一百微克�毫升的氧化鐵奈米粒子溶液中,由於巨噬細胞同時在冠狀動脈硬化,腫瘤的轉移等疾病現象中扮演重要的角色,因此是否可利用我們發現的現象,進行巨噬細胞的調節,則有待更進一步的探討. 幹細胞在組織工程上扮演舉足輕重的角色,因為其具有分化以及增生的能力,因此被認為具有修補受傷組織,作為器官移植等醫療用途.在文獻上也有許多的報告將幹細胞用於治療心肌梗塞,腦部疾病等.由於直接將幹細胞植入生物體內,我們無法清楚的了解這些幹細胞是否停留在原先的組織上,或是經由循環等路徑到達其他器官,因此有些研究學者利用氧化鐵奈米粒子將幹細胞進行標示,在磁振造影上用來追蹤幹細胞在生物體內的分布. 我們利用臨床上之氧化鐵奈米粒子Ferucarbotran 來進行幹細胞標示,發現Ferucarbotran可以直接用來標示幹細胞,不需要加入其他的藥物,並且這種標示方法可以達到相當高的細胞內氧化鐵濃度,在這種標示狀況下,幹細胞並沒有活性上的改變,粒線體的電位差也沒有變化,同時幹細胞的骨骼以及脂肪組織的分化能力都沒有受到改變.藉由我們的標示方法,我們順利的在臨床使用的磁振造影儀下進行掃描,可以清晰的看到單一細胞的影像.因此我們相信這種幹細胞標示的方式將可以用來進行幹細胞的活體追蹤. | zh_TW |
dc.description.abstract | Superparamagnetic iron oxide nanoparticles have been used as clinical magnetic resonance imaging contrast agents. They are composed of iron oxide core coated with biodegradable polymers such as dextran or carboxydextran for improving solubility and suspensibility. Once if they are delivered into human body, most of them will be ingested by circulating macrophages and reticulo-endothelial system that mostly resides in the liver. Clinically, they are used for detecting and differentiating hepatic tumors. Although certain percentages of these particles are ingested by macrophages, little is known about the physiological influence of these particles after ingested into cells.
We evaluated the physiological functions of macrophages including phagocytic activity, cellular migration, tumor necrosis factor-alpha(TNF-α) secretion, interleukin-1 beta (IL-1β) and nitric oxide excretions. There is decreased phagocytic activity but increased cell migration ability. The cytokine assays showed increased TNF-αand IL-1β secretion. There is also increase in nitric oxide secretion after nanoparticles ingestion. We conclude that macrophage physiological functions are altered after magnetic iron oxide nanoparticles ingestion. The impact on the whole living organism should be further investigated. Stem cells play important roles in the development of tissue engineering. It is proposed that stem cells could be used for tissue repair and organ transplantation. The magnetic iron oxide nanoparticles have been used for labeling of stem cells for visualizing the fate of the cells in living organisms. Most of the labeling techniques are achieved by incorporation with transfecting agents such as protamine sulfate. We developed a simple method by choosing one kind of magnetic iron oxide nanoparticles, Ferucarbotran that has carboxydextran coating instead of dextran coating. This method is simple and the viability, mitochondrial membrane potential, and reactive oxygen species are not altered. Moreover, the capacity of osteocyte and adipocyte differentiation is preserved. We evaluated the efficacy of labeling ability by visualizing the cells at 1.5 Tesla clinical magnetic resonance imaging system and up to single cells could be resolved. We conclude that this labeling method is efficacious and could be applied in the stem cell technology. In summery, the superparamagnetic iron oxide nanoparticles have different biological and medical application than materials at different size. Further evaluation of the impact of these particles on the biomedical science is beneficial in the development of nanotechnology and stem cell therapy. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T15:22:46Z (GMT). No. of bitstreams: 1 ntu-97-D94548004-1.pdf: 2048406 bytes, checksum: c366e04796acf20ddb15485154ef1b77 (MD5) Previous issue date: 2008 | en |
dc.description.tableofcontents | 目錄
Chapter 1 : Introduction 1 Mechanisms of MRI 1 Magnet and Nucleus 1 Resonance and Relaxation 2 Imaging 3 T1 Relaxation 3 T2 relaxation 4 Contrast medium 4 T1 relaxation agents 5 T2 contrast agents 8 Cellular and Molecular Imaging 10 Strategy for Targeting Molecules 11 Imaging modality 12 Chapter 2 : Biomedical effects of iron oxide nanoparticles toward macrophages 14 Introduction 14 Material and methods 16 Cell culture and iron oxide treatment 16 Morphology and particle uptake efficiency assay 17 Viability and proliferation test 18 Phagocytosis assay 19 Migration assay 20 TNF-alpha production analysis 20 Measurement by Enzyme linked-immuno-sorbent assay (ELISA) 20 Determination of TNF-alpha mRNA by reverse transcriptase polymerase chain reaction (RT-PCR) 21 Nitric Oxide Production Assay 22 Statistical analysis 22 Results 23 Morphology of cells and iron oxide uptake efficiency 23 Viability and Proliferation test 23 Phagocytosis assay 24 Migration assay 24 TNF-alpha production analysis 25 Nitric Oxide Production 25 Discussion 26 Morphology of cells and iron oxide uptake efficiency 26 Viability and proliferation 28 Migratory ability 28 Phagocytosis 29 TNF-alpha production 30 Nitric oxide production 30 Limitations 31 Conclusion 34 Figures 35 Chapter 3 : Biomedical response and application of iron oxide nanoparticles toward human mesenchymal stem cells 43 Introduction 43 Material and methods 46 Cell culture, SPIO labeling, and microscopy imaging for cell identification 46 Identification of Intracellular location of SPIO 47 Comparison of labeling efficiency of different SPIOs 48 Prussian blue staining and flow cytometry 49 Iron (Fe) content determination 49 Mitochondria membrane potential 50 Reactive Oxygen Species 50 Cell viability and proliferation 51 Cell differentiation capacity 51 MRI 52 Statistical analysis 53 Results 54 Cell labeling 54 Identification of Intracellular location of SPIO 54 Comparison of different clinically used SPIOs 55 Iron content 55 Mitochondrial membrane potential 55 Reactive oxygen species 55 Cell viability, proliferation and differentiation 56 Identification of single cells 56 Discussion 58 Cell types 58 Stem Cell labeling efficiency 58 Influence of SPIO on hMSCs 59 Image resolution 60 Limitations 61 Prospect 62 Conclusion 63 Figures 64 Chapter 4 : Summary and future works 76 Macrophages and SPIO 76 Human mesenchymal stem cells and SPIO 77 More applications of SPIO 79 References: 81 | |
dc.language.iso | en | |
dc.title | 氧化鐵奈米粒子之生物醫學效應以及應用 | zh_TW |
dc.title | Application and biomedical effects of iron oxide nanoparticles | en |
dc.type | Thesis | |
dc.date.schoolyear | 96-2 | |
dc.description.degree | 博士 | |
dc.contributor.coadvisor | 廖漢文(Hon-Man Liu) | |
dc.contributor.oralexamcommittee | 周必泰,許輔,林泰元 | |
dc.subject.keyword | 超順磁氧化鐵,奈米粒子,幹細胞,巨噬細胞,磁振造影, | zh_TW |
dc.subject.keyword | superparamagnetic iron oxide,nanoparticle,magnetic resonance imaging,stem cells,macrophage, | en |
dc.relation.page | 94 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2008-07-23 | |
dc.contributor.author-college | 工學院 | zh_TW |
dc.contributor.author-dept | 醫學工程學研究所 | zh_TW |
顯示於系所單位: | 醫學工程學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-97-1.pdf 目前未授權公開取用 | 2 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。